[HTML][HTML] Epidemiology of hepatitis E virus in European countries
D Lapa, MR Capobianchi, AR Garbuglia - International Journal of …, 2015 - mdpi.com
Over the last decade the seroprevalence of immunoglobulin (IgG) anti hepatitis E virus (HEV)
has been increasing in European countries and shows significant variability among …
has been increasing in European countries and shows significant variability among …
[HTML][HTML] The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease
AR Garbuglia, D Lapa, C Sias… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …
[HTML][HTML] Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
…, LE Lapini, A D'Abramo, S Cicalini, D Lapa… - …, 2022 - eurosurveillance.org
Since May 2022, an outbreak of monkeypox has been ongoing in non-endemic countries. We
report four cases in Italy in young adult men reporting condomless sexual intercourse. The …
report four cases in Italy in young adult men reporting condomless sexual intercourse. The …
Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
D Lapa, F Carletti, V Mazzotta, G Matusali… - The Lancet Infectious …, 2022 - thelancet.com
… With great interest, we read the findings presented by Daniele Lapa and colleagues, 1
showing the successful isolation of monkeypox viral DNA from the seminal fluid of an infected …
showing the successful isolation of monkeypox viral DNA from the seminal fluid of an infected …
SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection
F Colavita, D Lapa, F Carletti, E Lalle… - Annals of internal …, 2020 - acpjournals.org
Background: Coronavirus disease 2019 (COVID-19), the disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in China in …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in China in …
[HTML][HTML] Hepatitis C virus genetic variability, human immune response, and genome polymorphisms: which is the interplay?
D Lapa, AR Garbuglia, MR Capobianchi, P Del Porto - Cells, 2019 - mdpi.com
Hepatitis C virus (HCV) infection is the main cause of chronic hepatitis, affecting an estimated
150 million people worldwide. Initial exposure to HCV is most often followed by chronic …
150 million people worldwide. Initial exposure to HCV is most often followed by chronic …
[HTML][HTML] Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2
cellular cytopathic effects requires definition. We performed a comparative …
cellular cytopathic effects requires definition. We performed a comparative …
[HTML][HTML] 2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation
…, E Giombini, MC Greci, E Lalle, S Lanini, D Lapa… - International Journal of …, 2020 - Elsevier
Introduction Several recent case reports have described common early chest imaging findings
of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be …
of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be …
Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with …
…, E Cimini, E Grilli, R Bellagamba, D Lapa… - Clinical Infectious …, 2022 - academic.oup.com
Background Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently limited.
Aim of the study was to investigate immunogenicity according to current CD4 T-cell count …
Aim of the study was to investigate immunogenicity according to current CD4 T-cell count …
[HTML][HTML] ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients
Objective To assess in rheumatoid arthritis (RA) patients, treated with different immunosuppressive
therapies, the induction of SARS-CoV-2-specific immune response after vaccination …
therapies, the induction of SARS-CoV-2-specific immune response after vaccination …
